Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AGTC 0106

Drug Profile

AGTC 0106

Alternative Names: AGTC-0106; Alpha-1 antitrypsin deficiency gene therapy - Applied Genetic Technologies Corporation; rAAV1-CB-hAAT; Recombinant AAV-AAT vector gene therapy - AGTC

Latest Information Update: 22 Aug 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Applied Genetic Technologies Corporation
  • Developer Applied Genetic Technologies Corporation; National Heart, Lung and Blood Institute
  • Class Gene therapies
  • Mechanism of Action Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Alpha 1-antitrypsin deficiency
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alpha 1-antitrypsin deficiency

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 05 May 2016 Pharmacodynamics data from a phase I trial in Alpha-1-antitrypsin deficiency released by Applied Genetic Technologies Corporation
  • 20 Jan 2016 Pharmacodynamics data from a phase II trial in Alpha-1-antitrypsin deficiency released by Applied Genetic Technologies Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top